Adam F. Cohen
Amministratore Delegato presso Centre for Human Drug Research
Profilo
Adam F.
Cohen is the founder of Omnicomm Systems BV.
He is currently the Chief Executive Officer at Centre for Human Drug Research since 2015 and a Professor-Clinical Pharmacology at the University of Leiden since 1994.
Previously, he served as an Independent Director at OmniComm Systems, Inc., a Council-Medical Sciences at The Royal Netherlands Academy of Arts & Sciences, and a Member at The Health Council of the Netherlands.
Dr. Cohen obtained his doctorate degree from the University of Leiden in 1978 and 1986, and also holds an undergraduate degree from the same institution.
Posizioni attive di Adam F. Cohen
| Società | Posizione | Inizio |
|---|---|---|
Centre for Human Drug Research
 Centre for Human Drug Research BiotechnologyHealth Technology The Centre for Human Drug Research provides clinical drug research services. The private company is based in Leiden, Netherlands. Adam F. Cohen has been the CEO of the Dutch company since 1987. | Amministratore Delegato | - |
| University of Leiden | Corporate Officer/Principal | 01/03/1994 |
Precedenti posizioni note di Adam F. Cohen
| Società | Posizione | Fine |
|---|---|---|
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Corporate Officer/Principal | - |
| The Health Council of the Netherlands | Corporate Officer/Principal | - |
Omnicomm Systems BV
 Omnicomm Systems BV Packaged SoftwareTechnology Services Part of Anju Software, Inc., Omnicomm Systems BV is a Dutch company that develops clinical trial software. The company is based in Leiden, Netherlands. The company was founded by Adam F. Cohen. Omnicomm Systems was acquired by OmniComm Systems, Inc., part of Anju Software, Inc. from September 18, 2019 on November 12, 2013 for $0.97 million. | Fondatore | - |
| OMNICOMM SYSTEMS, INC. | Direttore/Membro del Consiglio | - |
Formazione di Adam F. Cohen
| University of Leiden | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
OmniComm Systems, Inc.
 OmniComm Systems, Inc. Packaged SoftwareTechnology Services OmniComm Systems, Inc. engages in providing software solutions in the field of sciences. It supports customers through innovative technologies in management of risks, regulatory compliance, and clinical operations in the field of pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers. Its products include TrialMaster, TrialOne, Acuity Analytics, AutoEncoder, IRTMaster, and. The company was founded by Randall G. Smith on November 19, 1996 and is headquartered in Fort Lauderdale, FL. | Technology Services |
Centre for Human Drug Research
Centre for Human Drug Research BiotechnologyHealth Technology The Centre for Human Drug Research provides clinical drug research services. The private company is based in Leiden, Netherlands. Adam F. Cohen has been the CEO of the Dutch company since 1987. | Health Technology |
| The Health Council of the Netherlands | |
Omnicomm Systems BV
Omnicomm Systems BV Packaged SoftwareTechnology Services Part of Anju Software, Inc., Omnicomm Systems BV is a Dutch company that develops clinical trial software. The company is based in Leiden, Netherlands. The company was founded by Adam F. Cohen. Omnicomm Systems was acquired by OmniComm Systems, Inc., part of Anju Software, Inc. from September 18, 2019 on November 12, 2013 for $0.97 million. | Technology Services |
The Royal Netherlands Academy of Arts & Sciences
The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Commercial Services |
- Borsa valori
- Insiders
- Adam F. Cohen
